LEXARIA BIOSCIENCE CORP's ticker is LEXX and the CUSIP is 52886N406. A total of 18 filers reported holding LEXARIA BIOSCIENCE CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,326 | +36.9% | 33,329 | 0.0% | 0.00% | – |
Q2 2023 | $24,340 | -73.2% | 33,329 | 0.0% | 0.00% | – |
Q1 2023 | $90,655 | +10.6% | 33,329 | 0.0% | 0.00% | – |
Q4 2022 | $81,989 | +1.2% | 33,329 | +0.5% | 0.00% | – |
Q3 2022 | $81,000 | -20.6% | 33,164 | -2.8% | 0.00% | – |
Q2 2022 | $102,000 | -8.9% | 34,122 | 0.0% | 0.00% | – |
Q1 2022 | $112,000 | -18.8% | 34,122 | 0.0% | 0.00% | – |
Q4 2021 | $138,000 | -28.5% | 34,122 | +10.7% | 0.00% | – |
Q3 2021 | $193,000 | +6.0% | 30,834 | +18.7% | 0.00% | – |
Q2 2021 | $182,000 | – | 25,976 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invenomic Capital Management LP | 365,212 | $1,088,000 | 0.08% |
Virtu Financial LLC | 10,975 | $33,000 | 0.00% |
Merit Financial Group, LLC | 21,267 | $63,000 | 0.00% |
Centiva Capital, LP | 14,159 | $42,000 | 0.00% |
VANGUARD GROUP INC | 34,122 | $102,000 | 0.00% |
UBS Group AG | 4,171 | $12,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 17,401 | $52,000 | 0.00% |
OSAIC HOLDINGS, INC. | 2,043 | $7,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,032 | $3,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |